Absent T Lymphocytes

Search Trials
A Study of NX-1607 in Adults With Advanced Malignancies
Status:
Recruiting
Last Changed:
Nov 4, 2021
First Changed:
Nov 4, 2021
Disease(s):
Ovarian Cancer, Epithelial
Intervention(s):
NX-1607
Long-term Follow-up of Subjects Treated With CARv3-TEAM-E T Cells
Status:
Not yet recruiting
Last Changed:
Aug 27, 2021
First Changed:
Aug 27, 2021
Disease(s):
Glioblastoma Recurrent, EGFR vIII Mutant
Intervention(s):
Disease assessmentsTumor BiopsyBlood test
⁸⁹Zr-Df-IAB22M2C PET/CT in Patients With Selected Solid Malignancies or Hodgkin's Lymphoma
Status:
Completed
Last Changed:
Sep 18, 2018
First Changed:
Apr 11, 2017
Disease(s):
Positron-Emission Tomography
Intervention(s):
⁸⁹Zr-Df-IAB22M2C Infusion
Combination Chemotherapy and Lenalidomide in Treating Patients With Newly Diagnosed Stage II-IV Peripheral T-cell Non-Hodgkin's Lymphoma
Status:
Active, not recruiting
Last Changed:
Jun 18, 2021
First Changed:
Sep 28, 2015
Disease(s):
Anaplastic Large Cell Lymphoma, ALK-Negative
Intervention(s):
Autologous Hematopoietic Stem Cell TransplantationCyclophosphamideDoxorubicin HydrochlorideEtoposideLaboratory Biomarker AnalysisLenalidomidePeripheral Blood Stem Cell TransplantationPrednisoneVincristine Sulfate
Rare Disease Patient Registry & Natural History Study – Coordination of Rare Diseases at Sanford
Status:
Recruiting
Last Changed:
Dec 10, 2020
First Changed:
Feb 15, 2013
Disease(s):
Rare Disorders

Connect. Empower. Inspire.